Iwona Kucharewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Iwona Kucharewicz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anna Bodzenta-Lukaszyk
Department of Allergology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland
3 shared publications Wlodzimierz Buczko
3 shared publications- Barbara Mroczko
Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland
2 shared publications - Dariusz Pawlak
Department of Pharmacodynamics, Medical University of Bialystok, 15-222 Bialystok, Poland
2 shared publications - Anna Tankiewicz-Kwedlo
Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland
1 shared publication - Ewa Chabielska
Department of Biopharmacy and Radiopharmacy, Medical University of Bialystok, 15-222 Bialystok, Poland
1 shared publication
Latest Publications
- Open Access
- 4 June 2008
- Published by VM Media Group sp. z o.o in Folia Histochemica et Cytobiologica
- Vol. 46 (2) , 199-203
The concentration of kynurenine in rat model of asthma.
The concentration of kynurenine in rat model of asthma.
- 4 June 2008
- Published by VM Media Group sp. z o.o in Folia Histochemica et Cytobiologica
- Vol. 46 (2) , 199-203
Open AccessThe concentration of kynurenine in rat model of asthma.
The concentration of kynurenine in rat model of asthma.
- 1 January 2007
- Vol. 17 (2) , 65-9
Basal serum tryptase level correlates with severity of hymenoptera sting and age.
Increased serum tryptase has been linked to the severity of the reaction after Hymenoptera stings. The aim of the study was to measure basal tryptase levels in patients with Hymenoptera venom allergy and investigate the possible correlation between these levels and the severity of sting reaction. One hundred nine patients were included in the study. Sixty-three were wasp venom-allergic and 46 were honey bee venom-allergic. Basal serum tryptase levels were measured by UniCAP. Basal serum tryptase levels were elevated in 12 (11%) of the 109 patients. Levels were 5.14 pg/L (3.62-5.84), 5.3 microg/L (2.94-6.54), 5.18 microg/L (3.71-6.25), and 6.98 microg/L (4.78-12.6), for patients with sting reactions of grade I, II, III and IV (as classified by Mueller), respectively. Basal serum tryptase levels correlated significantly with the sting reaction severity (r = 0.2752; P = .004) and with age (r = 0.2906; P = .002). Sting reaction severity also correlated with age (r = 0.3654; P = .001). Basal serum tryptase levels were found to be elevated in 11% of venom allergic patients and correlated significantly with both sting reaction severity and age.
- 1 January 2007
- Vol. 17 (2) , 65-9
Basal serum tryptase level correlates with severity of hymenoptera sting and age.
Increased serum tryptase has been linked to the severity of the reaction after Hymenoptera stings. The aim of the study was to measure basal tryptase levels in patients with Hymenoptera venom allergy and investigate the possible correlation between these levels and the severity of sting reaction. One hundred nine patients were included in the study. Sixty-three were wasp venom-allergic and 46 were honey bee venom-allergic. Basal serum tryptase levels were measured by UniCAP. Basal serum tryptase levels were elevated in 12 (11%) of the 109 patients. Levels were 5.14 pg/L (3.62-5.84), 5.3 microg/L (2.94-6.54), 5.18 microg/L (3.71-6.25), and 6.98 microg/L (4.78-12.6), for patients with sting reactions of grade I, II, III and IV (as classified by Mueller), respectively. Basal serum tryptase levels correlated significantly with the sting reaction severity (r = 0.2752; P = .004) and with age (r = 0.2906; P = .002). Sting reaction severity also correlated with age (r = 0.3654; P = .001). Basal serum tryptase levels were found to be elevated in 11% of venom allergic patients and correlated significantly with both sting reaction severity and age.
- 1 January 2003
- Published by Elsevier in Thrombosis Research
- Vol. 112 (1-2) , 1-7
The plasmin system in airway remodeling
- 1 January 2003
- Published by Elsevier in Thrombosis Research
- Vol. 112 (1-2) , 1-7
The plasmin system in airway remodeling
- Open Access
- 1 September 2000
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 1 (3) , 268-272
The antithrombotic effect of angiotensin-(1—7) closely resembles that of losartan
Angiotensin-(1-7) [Ang-(1-7)] is the bioactive peptide which may be responsible for some of the pharmacological effects of losartan. Our previous study has demonstrated the antithrombotic action of losartan in a model of experimental thrombosis. In the present study, we compared the antithrombotic action of losartan and Ang-(1-7). Acute (10 mg/kg, p.o.) and chronic (10 mg/kg, p.o., three weeks) losartan administration to spontaneously hypertensive rats (SHR) induced a decrease in thrombus weight (1.6±0.6 mg and 1.2±0.3 mg respectively vs. control 2.9±0.8 mg; p-6 and 10 —5 M) also reduced adhesion to fibrillar collagen (38.4±0.1% and 33.8±0.8% respectively vs. control 40.0±0.6%; p<0.05, p<0.001). There were no apparent changes in prothrombin time, activated partial thromboplastin time and euglobulin clot lysis time in losartan and Ang-(1-7)-treated groups. We conclude that, like losartan, Ang-(1-7) is able to act as an antithrombotic agent.
- 1 September 2000
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 1 (3) , 268-272
Open AccessThe antithrombotic effect of angiotensin-(1—7) closely resembles that of losartan
Angiotensin-(1-7) [Ang-(1-7)] is the bioactive peptide which may be responsible for some of the pharmacological effects of losartan. Our previous study has demonstrated the antithrombotic action of losartan in a model of experimental thrombosis. In the present study, we compared the antithrombotic action of losartan and Ang-(1-7). Acute (10 mg/kg, p.o.) and chronic (10 mg/kg, p.o., three weeks) losartan administration to spontaneously hypertensive rats (SHR) induced a decrease in thrombus weight (1.6±0.6 mg and 1.2±0.3 mg respectively vs. control 2.9±0.8 mg; p-6 and 10 —5 M) also reduced adhesion to fibrillar collagen (38.4±0.1% and 33.8±0.8% respectively vs. control 40.0±0.6%; p<0.05, p<0.001). There were no apparent changes in prothrombin time, activated partial thromboplastin time and euglobulin clot lysis time in losartan and Ang-(1-7)-treated groups. We conclude that, like losartan, Ang-(1-7) is able to act as an antithrombotic agent.